Xếp hạng trong cổ phiếu
#40641
Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies... Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies for cancer patients in the United States, specifically addressing challenges like tumor immune evasion and drug resistance. Its diverse oncology pipeline includes CM24, a humanized monoclonal antibody that targets and blocks carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1). Currently in Phase 2 clinical trials, CM24 is being investigated as a combination therapy with anti-PD-1 checkpoint inhibitors for treating pancreatic ductal adenocarcinoma. Another candidate is NT219, a small molecule compound in Phase 1/2 clinical trials, which functions by inhibiting insulin receptor substrate 1 and 2 (IRS1/2) and signal transducer and activator of transcription (STAT). This compound is being developed for recurrent and/or metastatic squamous cell carcinoma of the head and neck, or colorectal adenocarcinoma. Furthermore, IM1240, a multi-valent antibody designed to activate an anti-tumoral immune response against 5T4-positive tumors, is in its preclinical stage. The company has established significant collaborations, including an agreement with Bristol Myers Squibb Company for Phase 2 clinical trials to assess CM24 in combination with the PD-1 inhibitor nivolumab and chemotherapy, as well as a partnership with Mor Research Applications. Formerly known as Kitov Pharma Ltd., the company adopted the name Purple Biotech Ltd. in December 2020 and is headquartered in Rehovot, Israel.
Giá cổ phiếu
$0.00323826
Đồng bộ lần cuối: 2026-08-12
Vốn hóa thị trường
$104.81K
Giao dịch Purple Biotech Ltd. (PPBT)
Lịch sử chia tách cổ phiếu của Purple Biotech Ltd. (PPBT)
Cổ phiếu Purple Biotech Ltd. (mã: PPBT) đã trải qua tổng cộng 0 lần chia tách.
Lần chia tách gần nhất diễn ra vào ngày Aug 13, 2026.
Một cổ phiếu PPBT mua trước ngày Aug 13, 2026 hiện tương đương với 0 cổ phiếu PPBT.
Danh sách chia tách cổ phiếu
| Năm |
Chia tách |
Tỷ lệ |
Tỷ lệ cộng dồn |
|
Không đủ dữ liệu cho ngày được cung cấp. |
Chia tách cổ phiếu của các công ty tương tự hoặc đối thủ
| Công ty |
Số lần chia tách cổ phiếu |
Tỷ lệ cộng dồn |
Quốc gia |
|
|
1 |
x2 |
US
|
|
|
0 |
- |
NL
|
|
|
0 |
- |
CH
|
|
|
0 |
- |
KR
|
|
|
0 |
- |
BE
|
